Chow Tai Fook Jewellery Group Announces FY2023 Interim Results

EQS Newswire / 24/11/2022 / 16:45 UTC+8   Chow Tai Fook Jewellery Group Announces FY2023 Interim Results Results Highlights Despite the macro-economic challenges and pandemic-led business disruptions, the Group reported a resilient set of results as revenue rose 5.3% year-on-year to HK$46,535 million for 1HFY2023, supported by favourable store opening…

MHI and EGAT ink MoU to Strengthen Cooperation on Clean Power Generation in Thailand

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) and Thailand's largest power producer Electricity Generating Authority of Thailand (EGAT) signed a Memorandum of Understanding (MoU) to study and exchange information relating to clean power generation, hydrogen, carbon capture, utilization and storage (CCUS) technologies…

Consortium of Japan partners successfully promote domestic production and cost reduction for 5G core technology, the basis for next-generation communication standards

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - The University of Tokyo, Internet Initiative Japan (IIJ), APRESIA, and Fujitsu Limited have successfully developed Open Source Software for the Private 5G/6G Mobile System, realizing a domestically produced, low-cost 5G core network (5GC), the core technology of the 5G mobile…

EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services

HONG KONG, Nov 24, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its unaudited interim results for the six months ended 30…

Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting

TOKYO, Nov 24, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that the company will have a total of 34 poster presentations, including the latest data on its in-house discovered and developed anti-epileptic agent (AED) perampanel (product name: Fycompa) at the 76th American Epilepsy Society Annual…

Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use

EQS Newswire / 24/11/2022 / 09:48 UTC+8 Kintor Pharma announced completion of phase I trial of the world’s first PROTAC compound (GT20029) for topical use     Suzhou, November 24, 2022 - Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics,…

Komainu Secures MVP Licence from Dubai’s Virtual Assets Regulatory Authority

DUBAI, UAE, Nov 23, 2022 - (ACN Newswire via SEAPRWire.com) - Komainu (Custodian), a regulated digital asset custody provider built by institutions for institutions, has announced today that it has received the minimal viable product (MVP) licence from Dubai's Virtual Assets Regulatory Authority (VARA), following the issuance of its provisional…